Search results for " market" in Articles / App Notes
Article
The Lifecycle Change of Process Validation and Analytical Testing
Reliance on complex and sophisticated sales algorithms in the stock market is an example of this type of error. On the other hand, humans can make simple errors. Therefore, finding a balance between r…
Article
The Future of Biopharma
The current situation in the biopharmaceutical industry is exciting enough, with biosimilars, new technologies, personalized medicines, and opportunities in emerging markets. The industry, however, be…
Article
Challenges for biosimilar developers: A conversation with Dr. Howard Levine about new FDA draft guidelines
“First of all, there is the 12-year data exclusivity period which means that a biosimilar product in the US cannot come to market until 12 years after the reference product or innovator product was fi…
Article
Reviewing the Importance of Biosimilarity and Interchangeability
However, bringing a biosimilar to market has strict challenges because the biosimilar developer must have a large set of analytical similarity data compared to the innovator biologic. In addition, the…
Article
Developing oligonucleotide therapeutics with confidence
You will learn about:
• the oligonucleotide therapeutic market
• the therapeutics in development
• challenges you may face and key considerations to address those challenges
• how to …
Article
Principles of Cell Line Development
It also takes a closer look at where it fits into this wider process including:
Overall path to market
Key processes and methods
Tools and equipment
Key regulatory re…
Article
Innovative Chromatography Resins Can Improve Purity and Quality
Ongoing downstream challenges
Constraints still remain in downstream processing of mAbs, which continue to be the most successful segment of biological molecules in the market in terms of required…
Article
Genetic Vaccine Platforms Demonstrate Their Potential
“Traditional vaccines have been on the market much longer than genetic vaccines and, in most cases, can currently be made at a significantly lower cost,” Bleck. “Over time,” he adds, “these technologi…
Article
Reimagining Affordable Biosimilars
More than 300 active biopharmaceutical product licenses in the market today bear witness to increasing interest in targeted treatments. With an anticipated valuation of over $200 billion by 2022, this…
Article
Next Generation Process Chromatography
Seven years later, Cytiva would bring Fibro to the market following the acquisition of Puridify in 2017.
Fibro is a new chromatography platform that enables the purification of therapeutic antibod…